Predictive Oncology (NASDAQ:POAI) Changing the landscape of oncology drug discovery&enabling development of more effective therapies in the treatment of cancer.
Joined April 2018
- Tweets 685
- Following 3
- Followers 1,311
- Likes 306
242 Photos and videos
12 Nov 2022
We appreciate the open dialogue and look forward to this new chapter for Predictive Oncology. $POAI 2/2
20
2
27
12 Nov 2022
We wanted to extend our apologies for the technical difficulties with the shareholder call yesterday.If you weren’t able to connect for questions, we look forward to further discussion during a Townhall we're planning after Thanksgiving & will keep you posted w/details. $POAI 1/2
8
18
11 Nov 2022
Shareholders, if you are hoping to ask questions during our webcast, please register at this link. $POAI register.vevent.com/register…
4
1
13
20 Oct 2022
Predictive Oncology appoints Raymond F. Vennare as CEO. An accomplished senior executive in life sciences, Mr. Vennare brings more than three decades of experience building and launching innovative biotechnology companies.
Read more here: hubs.la/Q01qgNsH0. $POAI
18
2
22
19 Oct 2022
Recently, our SVP Pamela Bush, Ph.D. sat down with @CheckRare to share insight into our Proof of Concept Study—which demonstrated that our PeDAL platform can predict a tumor’s response to a drug with 92% accuracy. Check it out here: checkrare.com/using-artifici…
18 Oct 2022
Pamela Bush, PhD, of Predictive Oncology, talks about the company’s technology to use artificial intelligence #AI to develop cancer medications. @PredictiveOnc
checkrare.com/using-artifici…
2
2
17
27 Sep 2022
We're gearing up for the Augmented Intelligence (AI) in Drug Discovery Xchange in San Francisco this Friday. Predictive Oncology SVP Pamela A. Bush, Ph.D., will be on hand to deliver the keynote and network with attendees. Will we see you there? hubs.la/Q01n35Tm0
3
10
48
22 Sep 2022
Recently, we put our PeDAL platform to the test to prove its value as a tool for AI-driven drug discovery. This hands-on testing revealed exciting results. Get an advanced look at this impressive Proof of Concept report here: hubs.la/Q01n063-0
2
15
56
19 Sep 2022
We wish our best to CEO Mel Engle as he announces his retirement, effective Oct. 31. Mel has played an instrumental role in setting up Predictive Oncology for the next stage of growth. This includes several key developments to further strengthen our offerings in drug development.
6
4
45
4 Aug 2022
Please join us for a shareholder earnings call on Friday, August 12, at 12:00 PM ET.
To register and view the webcast, please go to this link: edge.media-server.com/mmc/p/….
For Q&A’s, please register here: register.vevent.com/register…
$POAI
14
7
48
26 Jul 2022
Predictive Oncology strengthens business and product offerings with the appointment of Chief Scientific Officer, Julia Kirshner, Ph.D., and consolidation and expansion of its research and development arm. $POAI investors.predictive-oncolog…
11
6
34
21 Jul 2022
We are driven by the impact we have in reducing risk & moving candidates forward confidently with 3D cell culture technology. We're producing more reliable outcomes in drug development and advancing anticancer drug candidates with our zPREDICTA line & Labcorp partnership. $POAI
6
21
86
1 Jul 2022
At the heart of POAI is a team of people who share a dedication in the fight against cancer. Some affected personally-themselves or with others. Behind the business side is a deep motivation. We are in this for the long run. This is just one story of many.
linkedin.com/posts/prmarketi…
11
5
28
28 Jun 2022
Congratulations to Predictive Oncology's own Dr. Larry DeLucas for being named to the Top 50 Over 50! While we know Dr. DeLucas is talented beyond measure, we appreciate it when our leaders are recognized by others for their many achievements. $POAI #top50over50 #drugdevelopment
3
5
56
1 Jun 2022
Imagine the future we can create together. Meet with us at BIO 2022 in San Diego, June 13-16! Find Predictive Oncology in the partnering system to meet at the largest gathering of the global biotech community! #BIO2022 $POAI #POAI #AI #drugdiscovery share.bio.org/s/n2apT2FYNRF9…
6
9
50
24 May 2022
We are looking forward to today's shareholder call at 11 a.m. ET where you will have an opportunity to hear about our earnings report, product updates and commercialization efforts underway. Then, we’ll open up for Q&As. To register: predictive-oncology.com/shar… $POAI #POAI
7
3
29
17 May 2022
Please join us for a shareholder call on Tuesday, May 24, at 11 a.m. ET. You’ll have an opportunity to hear about our earnings report, product updates and commercialization efforts underway. Then, we’ll open up the discussion for Q&As. Register: predictive-oncology.com/shar…
15
5
42
10 May 2022
Investors, mark your calendars for a shareholder call on May 24 at 11 ET. We'll share about earnings, new developments and commercialization efforts. There will also be an opportunity for Q&A's. We'll be sharing details, so please stay tuned for registration information. #POAI
31
16
109
10 May 2022
These are exciting days at Predictive Oncology as we focus on the commercialization of our products. This article captures the vision and heart of our mission.
proactiveinvestors.com/compa…
#ai #oncologyresearch #drugdiscovery #drugdevelopment #cancerresearch #investors #poai
9
15
48